Cryptococcus neoformans is an environmental yeast found worldwide that causes lethal brain infections, particularly in immunocompromised hosts. In 2016, there were 280,000 cases of cryptococcal meningitis in the HIV+ population, two-thirds of them fatal; other immunocompromised patients are also affected. The burden of cryptococcal disease and the limits of current chemotherapy create a pressing need for improved treatment. One hindrance to the development of new therapies is lack of understanding of how this pathogen breaches the barriers protecting the brain. Here we describe a tool for investigating this process. This simple in vitro blood-brain-barrier (BBB) model, based on a human brain endothelial cell line grown on a permeable membrane, may be used to assay the BBB transmigration of C. neoformans or other neurotropic pathogens. © 2019 by John Wiley & Sons, Inc.
Keyphrases
- blood brain barrier
- cerebral ischemia
- resting state
- white matter
- end stage renal disease
- ejection fraction
- endothelial cells
- functional connectivity
- antiretroviral therapy
- hepatitis c virus
- respiratory failure
- hiv infected
- high throughput
- human immunodeficiency virus
- squamous cell carcinoma
- intensive care unit
- peritoneal dialysis
- multiple sclerosis
- hiv aids
- hiv testing
- risk assessment
- locally advanced
- patient reported outcomes
- radiation therapy
- climate change
- patient reported
- human health
- case control